Taking a look at what insiders are doing to gauge the Allogene Therapeutics Inc (ALLO)’s direction
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Allogene Therapeutics Inc shares valued at $683 were purchased by Parker Geoffrey M. on Jan 30 ’24. At $3.60 per share, Parker Geoffrey M. acquired 190 shares. The insider’s holdings grew to 819,590 shares […]
Negative sentiment towards ALLO reflected by a jump of 15.5% in short interest
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Allogene Therapeutics Inc shares valued at $683 were purchased by Parker Geoffrey M. on Jan 30 ’24. At $3.60 per share, Parker Geoffrey M. acquired 190 shares. The insider’s holdings grew to 819,590 shares worth approximately $3.27 […]
Allogene Therapeutics Inc [ALLO] Records 50-Day SMA of $4.45
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Allogene Therapeutics Inc shares valued at $683 were purchased by Parker Geoffrey M. on Jan 30 ’24. At $3.60 per share, Parker Geoffrey M. acquired 190 shares. The insider’s holdings grew to 819,590 shares worth approximately $3.35 […]
Analyzing Allogene Therapeutics Inc (ALLO) After Recent Trading Activity
Allogene Therapeutics Inc’s recently made public that its CHIEF FINANCIAL OFFICER Parker Geoffrey M. acquired Company’s shares for reported $683.0 on Jan 30 ’24. In the deal valued at $3.60 per share,190 shares were bought. As a result of this transaction, Parker Geoffrey M. now holds 819,590 shares worth roughly $3.45 million. Then, MESSEMER DEBORAH […]
Allogene Therapeutics, Inc. (ALLO) Stock Dipping in Aftermarket, Here’s Why
Allogene Therapeutics, Inc. (ALLO), a clinical-stage immuno-oncology company, has dipped 32.73% and hence, ALLO stock was trading at $16.40 when last checked. The reason for this massive decline seems to be the FDA clinical hold of AlloCAR T trials. On Thursday, ALLO stock closed the day at 24.338% after increasing 1.71%. FDA hold over AlloCAR […]
